<?xml version="1.0" encoding="UTF-8"?>
<p id="p0165">There are currently several clinical trials of chloroquine for COVID-19, either as monotherapy or in combination with other medications such as azithromycin [
 <xref rid="bb0560" ref-type="bibr">112</xref>]. A non-randomized clinical trial reported the reduction of the viral load from the hydroxychloroquine-azithromycin combination in twenty COVID-19 patients but failed to report the critical clinical outcomes, including death [
 <xref rid="bb0575" ref-type="bibr">115</xref>]. Chloroquine and hydroxychloroquine are the immunomodulatory drugs with potential antiviral effects. However, there are some long-known clinical side-effects and interactions with other medications. It is still premature to conclude the role of chloroquine and hydroxychloroquine in COVID-19, while several clinical trials are on their ways [
 <xref rid="bb0580" ref-type="bibr">116</xref>].
</p>
